AAAAAA

   
Results: 1-25 |

Table of contents of journal:

Results: 25

Authors: Manolagas, SC Weinstein, RS Jilka, RL
Citation: Sc. Manolagas et al., Basic principles of bone physiology, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 1-20

Authors: Grill, V Rankin, W Martin, TJ
Citation: V. Grill et al., Humoral hypercalcemia of malignancy: The discovery of PTHrP, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 21-40

Authors: Yoneda, T Williams, PJ Myoi, A Michigami, T Mbalaviele, G
Citation: T. Yoneda et al., Cellular and molecular mechanisms of development of skeletal metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 41-69

Authors: Goltzman, D Rabbani, SA
Citation: D. Goltzman et Sa. Rabbani, Pathogenesis of osteoblastic metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 71-84

Authors: Rubens, RD
Citation: Rd. Rubens, Clinical aspects of bone metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 85-96

Authors: Pecherstorfer, M Vesely, M
Citation: M. Pecherstorfer et M. Vesely, Diagnosis and monitoring of bone metastases: Clinical means, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 97-129

Authors: Cook, GJR Fogelman, I
Citation: Gjr. Cook et I. Fogelman, Diagnosis and monitoring of bone metastases: Scintigraphy, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 131-154

Authors: Parsa, M Murphey, MD
Citation: M. Parsa et Md. Murphey, Radiographic diagnosis and monitoring of bone metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 155-195

Authors: Hilkens, J Bonfrer, H
Citation: J. Hilkens et H. Bonfrer, Diagnosis and monitoring of bone metastases: Serum tumor markers, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 197-212

Authors: Fontana, A Garnero, P Delmas, PD
Citation: A. Fontana et al., Markers of bone turnover in diagnosis and monitoring of bone metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 213-226

Authors: Theriault, RL Hortobagyi, GN
Citation: Rl. Theriault et Gn. Hortobagyi, Treatment of bone metastases: Chemo- and hormone therapy, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 227-243

Authors: Koshy, RC Grossman, SA
Citation: Rc. Koshy et Sa. Grossman, Treatment of bone pain, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 245-261

Authors: Hoskin, PJ
Citation: Pj. Hoskin, Radiotherapy, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 263-286

Authors: Preston, DF Baxter, KG Schiefelbein, M Spicer, JA
Citation: Df. Preston et al., Palliation of painful bone metastases: Radioactive isotopes, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 287-304

Authors: Rubert, CK Henshaw, RM Malawer, MM
Citation: Ck. Rubert et al., Orthopedic management of skeletal metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 305-356

Authors: Fleisch, HA
Citation: Ha. Fleisch, Bisphosphonates: Introduction and mechanisms of action in tumor prevention, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 357-376

Authors: Russell, RG Croucher, PJ Rogers, MJ
Citation: Rg. Russell et al., Clinical pharmacology of bisphosphonates, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 377-392

Authors: Ralston, SH
Citation: Sh. Ralston, Treatment of tumor-induced hypercalcemia, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 393-408

Authors: Coleman, RE
Citation: Re. Coleman, Treatment of tumor-induced osteolysis and prevention of skeletal-related events in patients with bone metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 409-434

Authors: Paterson, AHG
Citation: Ahg. Paterson, Prospects of bisphosphonates: for the prevention of bone metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 435-455

Authors: Kanis, JA McCloskey, EV
Citation: Ja. Kanis et Ev. Mccloskey, Bisphosphonates in the treatment of multiple myeloma, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 457-481

Authors: Warrell, RP
Citation: Rp. Warrell, Gallium nitrate and bone metastases, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 483-492

Authors: Winding, B Jorgensen, HL Christiansen, C
Citation: B. Winding et al., Osteoporosis in patients with a history of breast cancer: Causes and diagnosis, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 493-514

Authors: Pritchard, KI
Citation: Ki. Pritchard, Osteoporosis in patients with a history of breast cancer treated with estrogen-replacement therapy, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 515-537

Authors: Thiebaud, D Burckhardt, P
Citation: D. Thiebaud et P. Burckhardt, Osteoporosis in patients with a history of breast cancer: Bisphosphonates and other drugs, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 539-554
Risultati: 1-25 |